ArticleCureus2025
Brain MRI Revealing the Probable Pathophysiology of Neuropsychiatric Lupus: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Systemic lupus erythematosus (SLE) is a chronic systemic autoimmune disease with a wide array of manifestations in different organ systems. Involvement of the central nervous system (CNS), also known as neuropsychiatric SLE (NPSLE), often presents with seizures, mental status changes, focal neurological findings, and cognitive impairment. While many underlying pathophysiologic mechanisms have been described, no unifying etiology has been determined for NPSLE, thus complicating treatment. We highlight the case of a 41-year-old female with SLE who presented to the emergency department after several generalized tonic-clonic seizure episodes. On physical examination, she was oriented only to self, had poor speech production, and responded only to noxious stimuli. Electroencephalography (EEG) showed right temporal focal slowing followed by a right temporal focal onset seizure. The patient was started on levetiracetam, lacosamide, and valproic acid. Pertinent lab results showed active systemic lupus. Her brain MRI revealed relatively symmetric bilateral medial temporal fluid-attenuated inversion recovery (FLAIR) hyperintensities compatible with limbic encephalitis. Her neurological condition and seizures persisted despite treatment with multiple anticonvulsants and oral prednisone. Once intravenous immunoglobulin (IVIg) was initiated, rapid symptom relief was achieved within 48 hours in refractory NPSLE with limbic encephalitis features, highlighting its efficacy when anticonvulsants (levetiracetam, lacosamide, valproic acid) and steroids (prednisone 60 mg) fail. This case demonstrates the importance of understanding the various underlying pathophysiologies of NPSLE to better target clinical management. The use of modern neuroimaging MRI techniques may aid in this pursuit.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.